Marshall R J, Muir A W, Winslow E
Br J Pharmacol. 1983 Jan;78(1):165-71. doi: 10.1111/j.1476-5381.1983.tb09377.x.
1 The effects of agents which produce membrane stabilization (class I), beta 1-adrenoceptor blockade (class II), prolongation of the cardiac action potential (class III) or inhibition of the slow inward current (class IV) were investigated for their ability to increase the ventricular fibrillation threshold (VFT) or to modify the fall in VFT consequent upon coronary artery ligation in the anaesthetized rat. 2 The class I agent, Org6001, increased VFT of normal myocardium and in lower doses reduced the postligation fall in VFT. 3 The class II agent, metoprolol, failed to increase VFT of normal myocardium but reduced the postligation fall. 4 The class III agent, melperone, increased VFT of both normal and ischaemic myocardium whereas the class IV agent, nifedipine failed to influence VFT in either region. 5 Bepridil (class I and IV) was similar to Org6001 and sotalol (class II and III) in that it increased VFT of normal myocardium and in lower doses reduced the postligation fall in VFT. 6 Measurement of VFT before and after coronary artery ligation in the rat constitutes a rapid and reproducible screen to detect antifibrillatory activity. 7 The results also suggest that in the rat, the low currents used (approximately 400 microA) do not release substantial quantities of catecholamines whereas these may be released by coronary artery ligation.
1 研究了具有膜稳定作用的药物(I类)、β1肾上腺素能受体阻滞剂(II类)、延长心脏动作电位的药物(III类)或抑制慢内向电流的药物(IV类)提高麻醉大鼠室颤阈值(VFT)或改变冠状动脉结扎后VFT下降的能力。2 I类药物Org6001提高了正常心肌的VFT,低剂量时可减少结扎后VFT的下降。3 II类药物美托洛尔未能提高正常心肌的VFT,但可减少结扎后VFT的下降。4 III类药物美哌隆提高了正常心肌和缺血心肌的VFT,而IV类药物硝苯地平在两个区域均未影响VFT。5 苄普地尔(I类和IV类)与Org6001相似,索他洛尔(II类和III类)也相似,即它们提高了正常心肌的VFT,低剂量时可减少结扎后VFT的下降。6 测量大鼠冠状动脉结扎前后的VFT构成了一种快速且可重复的筛选方法,以检测抗纤颤活性。7 结果还表明,在大鼠中,所使用的低电流(约400微安)不会释放大量儿茶酚胺,而冠状动脉结扎可能会释放这些儿茶酚胺。